369 related articles for article (PubMed ID: 19201859)
1. Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.
Fernandez DR; Telarico T; Bonilla E; Li Q; Banerjee S; Middleton FA; Phillips PE; Crow MK; Oess S; Muller-Esterl W; Perl A
J Immunol; 2009 Feb; 182(4):2063-73. PubMed ID: 19201859
[TBL] [Abstract][Full Text] [Related]
2. T-cell and B-cell signaling biomarkers and treatment targets in lupus.
Perl A; Fernandez DR; Telarico T; Doherty E; Francis L; Phillips PE
Curr Opin Rheumatol; 2009 Sep; 21(5):454-64. PubMed ID: 19550330
[TBL] [Abstract][Full Text] [Related]
3. Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/RAB4 expression and mTOR activation.
Godavarthy A; Kelly R; Jimah J; Beckford M; Caza T; Fernandez D; Huang N; Duarte M; Lewis J; Fadel HJ; Poeschla EM; Banki K; Perl A
JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31805010
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection.
Nagy G; Ward J; Mosser DD; Koncz A; Gergely P; Stancato C; Qian Y; Fernandez D; Niland B; Grossman CE; Telarico T; Banki K; Perl A
J Biol Chem; 2006 Nov; 281(45):34574-91. PubMed ID: 16935861
[TBL] [Abstract][Full Text] [Related]
5. HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE.
Caza TN; Fernandez DR; Talaber G; Oaks Z; Haas M; Madaio MP; Lai ZW; Miklossy G; Singh RR; Chudakov DM; Malorni W; Middleton F; Banki K; Perl A
Ann Rheum Dis; 2014 Oct; 73(10):1888-97. PubMed ID: 23897774
[TBL] [Abstract][Full Text] [Related]
6. Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE.
Perl A; Nagy G; Koncz A; Gergely P; Fernandez D; Doherty E; Telarico T; Bonilla E; Phillips PE
Autoimmunity; 2008 May; 41(4):287-97. PubMed ID: 18432409
[TBL] [Abstract][Full Text] [Related]
7. Endogenous retroviral pathogenesis in lupus.
Perl A; Fernandez D; Telarico T; Phillips PE
Curr Opin Rheumatol; 2010 Sep; 22(5):483-92. PubMed ID: 20644481
[TBL] [Abstract][Full Text] [Related]
8. HRES-1/Rab4 promotes the formation of LC3(+) autophagosomes and the accumulation of mitochondria during autophagy.
Talaber G; Miklossy G; Oaks Z; Liu Y; Tooze SA; Chudakov DM; Banki K; Perl A
PLoS One; 2014; 9(1):e84392. PubMed ID: 24404161
[TBL] [Abstract][Full Text] [Related]
9. Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.
Perl A
Autoimmunity; 2010 Feb; 43(1):32-47. PubMed ID: 20001421
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.
Fernandez D; Bonilla E; Mirza N; Niland B; Perl A
Arthritis Rheum; 2006 Sep; 54(9):2983-8. PubMed ID: 16947529
[TBL] [Abstract][Full Text] [Related]
11. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus.
Enyedy EJ; Nambiar MP; Liossis SN; Dennis G; Kammer GM; Tsokos GC
Arthritis Rheum; 2001 May; 44(5):1114-21. PubMed ID: 11352243
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus.
Lai ZW; Borsuk R; Shadakshari A; Yu J; Dawood M; Garcia R; Francis L; Tily H; Bartos A; Faraone SV; Phillips P; Perl A
J Immunol; 2013 Sep; 191(5):2236-46. PubMed ID: 23913957
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4
Chen S; Wang Y; Qin H; Lin J; Xie L; Chen S; Liang J; Xu J
Lupus; 2019 Apr; 28(4):510-519. PubMed ID: 30760089
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells.
Nagy G; Barcza M; Gonchoroff N; Phillips PE; Perl A
J Immunol; 2004 Sep; 173(6):3676-83. PubMed ID: 15356113
[TBL] [Abstract][Full Text] [Related]
15. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.
Lin JT; Lineberry NB; Kattah MG; Su LL; Utz PJ; Fathman CG; Wu L
J Immunol; 2009 May; 182(10):5919-28. PubMed ID: 19414743
[TBL] [Abstract][Full Text] [Related]
16. Metabolic control of T cell activation and death in SLE.
Fernandez D; Perl A
Autoimmun Rev; 2009 Jan; 8(3):184-9. PubMed ID: 18722557
[TBL] [Abstract][Full Text] [Related]
17. Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus.
Gómez-Martín D; Ibarra-Sánchez M; Romo-Tena J; Cruz-Ruíz J; Esparza-López J; Galindo-Campos M; Díaz-Zamudio M; Alcocer-Varela J
Arthritis Rheum; 2013 Apr; 65(4):1032-42. PubMed ID: 23280105
[TBL] [Abstract][Full Text] [Related]
18. E4BP4 overexpression: a protective mechanism in CD4+ T cells from SLE patients.
Zhao M; Liu Q; Liang G; Wang L; Luo S; Tang Q; Zhao H; Su Y; Yung S; Chan TM; Lu Q
J Autoimmun; 2013 Mar; 41():152-60. PubMed ID: 23340290
[TBL] [Abstract][Full Text] [Related]
19. DNA microarray gene expression profile of T cells with the splice variants of TCRzeta mRNA observed in systemic lupus erythematosus.
Tsuzaka K; Nozaki K; Kumazawa C; Shiraishi K; Setoyama Y; Yoshimoto K; Suzuki K; Abe T; Takeuchi T
J Immunol; 2006 Jan; 176(2):949-56. PubMed ID: 16393980
[TBL] [Abstract][Full Text] [Related]
20. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.
Liossis SN; Ding XZ; Dennis GJ; Tsokos GC
J Clin Invest; 1998 Apr; 101(7):1448-57. PubMed ID: 9525988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
